OPV Lifescience Partners
email opv.lsp at ix.netcom.com
fax 415 674-1965
OPV Lifescience Partners has been retained to identify and place a
Director of Operations for a cutting edge genetic reference lab.
Please read the position description and determine whether you are an
appropriate candidate.
If you are please email ( no attachments) a resume and cover letter to
opv.lsp at ix.netcom.com or fax us at 415 674 1965.
All resumes will be reviewed, please do not attempt to contact our
client directly as we are the retained agent for this position search
and your direct contact will not improve chances of placement.
We appreciate your time and immediate application for this position.
_______________________________________________________________________
______
Position Description
Director of Operations
REPORTS TO: President, Myriad Genetic Laboratories, Inc.
RESPONSIBILITIES:
The Director of Operations will have responsibility for managing
day-to-day operations of what will become a very high volume,
state-of-the-art genetic testing laboratory. This person will be
responsible for the developme
nt, planning, carrying out and control of testing methods, processes
and operations. The Director of Operations will be responsible for
hiring, managing and motivating a supervisory team through a major
scale up in capac
ity and service volume.
Experience planning, implementing and maintaining of clinical
laboratory procedures, processes and operations at the highest
professional standards;
Outstanding people skills for hiring, directing and motivating key
personnel.
History of hands on management and getting things done.
Experience with laboratory processes based on DNA testing.
Specifically, this individual will be responsible for planning,
organizing and managing the scale up and operation of a rapidly growing
commercial clinical laboratory. The Director of Operations will be
responsible for:
Producing accurate test results in a turnaround time sensitive service
business.
Developing processes and technologies to improve service, reduce costs
and assure continued compliance with CLIA and other regulatory.
Assuring timely and effective responses to customer inquiries and
complaints.
Planning and coordinating the scale up of manpower, equipment,
facilities, materials and controls to deliver superior service as
volume expands.
EDUCATION:
Undergraduate degree in life science
An advanced degree in molecular biology, genetics.
CANDIDATE QUALIFICATIONS:
A minimum of five years management and supervisory experience in a
clinical reference laboratory.
Excellent management and communication skills, both verbal and
written.
The ability to deal effectively with all levels of employees.
A keen sense of differences in disciplines and the ability to
affect team performance.
A solid understanding of service goals, including accuracy,
turnaround time and customer satisfaction.
PROFILE:
Highly energetic, results oriented and dedicated to achieving
established and personally defined goals.
Excellent interpersonal, motivational and communication skills.
Strong leadership skills; exhibit a strong presence and ability to
develop and command the respect of others.
A depth of management experience and ability to take charge of the
major undertaking involved in this position.
Technical capabilities to understand and incorporate the technologies
used in Myriad Labs' testing into the factors for success and economy.
(Board certification for DNA testing a plus.)
Sensitivity to the social and ethical issues that surround the right of
privacy and the potential discriminatory ways disease predisposition
testing might be used if inadequate controls existed.
An ability to communicate well with both superiors and subordinates in
developing and completing multiple projects in a result driven
environment.
LOCATION: Salt Lake City, Utah
COMPENSATION
A compensation package to include a base salary between ($70,000 to
$80,000) and relocation assistance based on the candidate's situation.
OPPORTUNITY:
To build a premier genetic testing service laboratory. Myriad Labs
offers an opportunity to make a significant change in testing that will
result in a meaningful improvement in the quality of early detection
and treatment for major diseases.
